. Author manuscript; available in PMC: 2020 Sep 11.

Published in final edited form as: Cell Host Microbe. 2019 Sep 11;26(3):336–346.e3. doi: 10.1016/j.chom.2019.08.014

Table 3.

Odds ratio (OR) estimates for log₁₀(ID50) and covariates based on the model of infection risk conditional on log₁₀(ID50), epitope of the bNAb, challenge virus, and the interaction between log₁₀(ID50) and challenge virus (SF162P3 vs. other). See also Table S3.

	OR	95% CI	p-value
log₁₀(ID50) for virus other than SHIV_SF162P3	0.012	(0.003,0.054)	<0.001
log₁₀(ID50) for virus SHIV_SF162P3	0.17	(0.057,0.51)	0.002
Epitope relative to MPER
CD4 Binding Site	801	(58, 16243)	<0.001
V1V2	1030	(43, 24887)	< 0.001
V3-glycan	4120	(173, 97943)	< 0.001
Virus relative to SHIV_BaL/SHIV_BaLP4
SHIV_SF162P4	1.98	(0.29,13.43)	0.49
SHIV_325C	0.008	(0,0.18)	0.002
SHIV_327C	0.83	(0.18,3.79)	0.81
SHIV_AD8EO	0.52	(0.12,2.17)	0.37
SHIV_BG505	0.095	(0.016,0.57)	0.01
SHIV_SF162P3	0	(0,0.016)	<0.001